Using biomarkers to guide the discharge of heart failure patients from the hospital

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multi-centre, single blind, randomized study aims to improve the discharge process for patients admitted with acute decompensated heart failure. Participants will be randomized to either a biomarker guided discharge algorithm or usual care, with NTproBNP and other biomarkers measured shortly after admission. Based on these biomarker levels, patients will be stratified into lower and medium-higher risk pathways, with tailored discharge planning and follow-up care. The study will monitor participants for 30 days post-discharge and conduct follow-up evaluations at 3 and 6 months.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients admitted to hospital with a primary diagnosis of acute decompensated heart failure, compatible with the modified Framingham criteria

Exclusion Criteria:

* Patient unable to provide blood samples or cannot participate in follow-up
* Patient with end stage organ failure

  * Kidney: creatinine \>350 μmol/L or Estimated GFR ≤15 ml/min
  * Liver dysfunction: liver function test \>2.5 times normal
  * Lungs: pulmonary FEV1\<50% predicted
* Patient requiring intubation
* Patient with an admission NTproBNP measurement of \>30,000 pg/ml
* Patient listed for heart transplant, or admitted specifically for transplant workup
* Patient in cardiogenic shock
* Patient with life expectancy of less than 6 months, or has major co-morbidities such as new stroke, cancer, pneumonia, or other serious life threatening illness
* Patient with conditions that will make it difficult to discharge from hospital such as a fall or waiting for a long term care bed
* Any other significant disease or disorder which, in the opinion of the Investigator, may either put the patient at risk because of participation in the trial, or may bias the result of the trial, or the patient's ability to participate in the trial
* Patient who has participated in another research trial involving an investigational product in the past 30 days

Where it's running

• University of Ottawa Heart Institute
  Ottawa, Ontario, Canada Recruiting

Study contacts

• Principal investigator: Peter Liu, MD — Ottawa Heart Institute Research Corporation
• Study coordinator: Ermina Moga, MD
• Email: emoga@ottawaheart.ca
• Phone: 613-696-7000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using Apple Watch data to predict heart failure outcomes

  This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.

  Recruiting University Medical Center Goettingen · Goettigen, Lower Saxony · NCT06819618

• Comparing Aortix Device to Diuretics for Acute Heart Failure

  This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.

  Recruiting at 33 sites Procyrion · Phoenix, Arizona and 49 other locations · NCT05677100

• Using intravenous albumin to prevent worsening kidney function in heart failure patients

  This study is testing if giving heart failure patients a special protein through an IV can help their kidneys work better when they're also having liver problems.

  Recruiting Phase 3 Democritus University of Thrace · Alexandroupoli, Evros · NCT06630923

• Using a wearable vest to measure lung fluid in heart failure patients

  This study is testing a new wearable vest that measures lung fluid in heart failure patients to see if it can help them get better treatment compared to standard care.

  Recruiting University of California, San Francisco · San Francisco, California · NCT03586336

• Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS

  Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.

  Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital · Beijing · NCT07912086

• Tailored digital support to cut sedentary time in long-term cardiac rehab

  In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.

  Recruiting University of Lisbon · Lisbon, Lisbon District · NCT07910812

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.